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Abstract
BRCA1 promotes DNA repair through interactions with multiple proteins, including CtIP and FANCJ (also known as BRIP1/
BACH1). While CtIP facilitates DNA end resection when de-acetylated, the function of FANCJ in repair processing is less well
defined. Here, we report that FANCJ is also acetylated. Preventing FANCJ acetylation at lysine 1249 does not interfere with
the ability of cells to survive DNA interstrand crosslinks (ICLs). However, resistance is achieved with reduced reliance on
recombination. Mechanistically, FANCJ acetylation facilitates DNA end processing required for repair and checkpoint
signaling. This conclusion was based on the finding that FANCJ and its acetylation were required for robust RPA foci
formation, RPA phosphorylation, and Rad51 foci formation in response to camptothecin (CPT). Furthermore, both
preventing and mimicking FANCJ acetylation at lysine 1249 disrupts FANCJ function in checkpoint maintenance. Thus, we
propose that the dynamic regulation of FANCJ acetylation is critical for robust DNA damage response, recombination-based
processing, and ultimately checkpoint maintenance.
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Introduction
The hereditary breast cancer associated gene product, BRCA1
is an essential tumor suppressor. To promote genomic stability,
BRCA1 interacts with multiple protein partners. In particular,
through its C-terminal BRCT repeats, BRCA1 directly interacts
with Abraxas, CtIP and FANCJ (also known as BRIP1 or BACH1
(BRCA1-associated C-terminal helicase 1)). These BRCT-inter-
acting proteins contribute to the function of BRCA1 in the DNA
damage response (DDR). Abraxas serves to localize BRCA1 to
sites of DNA damage and CtIP promotes the initiation of DNA
end resection, which is critical for HR [1–3]. FANCJ also
participates in localizing BRCA1 to sites of DNA damage, in DNA
repair, and in checkpoint signaling; however, its distinct function is
less clear.
Elucidating how FANCJ functions in the DDR is important, as
mutations in the FANCJ gene are associated with hereditary breast
cancer as well as with the rare cancer prone syndrome Fanconi
anemia (FA) within the FANCJ patient complementation group
(FA-J) [4]. As a DEAH-family helicase, it is expected that FANCJ
metabolizes DNA substrates to facilitate DNA repair. Consistent
with this idea, recombinant-FANCJ is a 59-39 helicase and
translocase that can unwind D-loops and displace RAD51 [5].
In cells, FANCJ also localizes to sites of DNA damage.
Furthermore, when FANCJ is absent, catalytically inactive, or
lacks BRCA1 binding, cells display defects in double strand break
repair (DSBR) and HR [6–9]. Recently, FANCJ was identified as
a factor essential for maintaining the DNA damage induced
checkpoint in response to ionizing radiation [10]. Despite these
findings, FANCJ-deficient cells are only mildly sensitive to agents
that induce DSBs [11].
To explain these findings, it has been proposed that FANCJ
functions in DSBR, but has a more significant role in processing
replication forks stalled at lesions, such as DNA interstrand
crosslinks (ICLs). In support of this idea, FANCJ-null cells, similar
to other FA patient cells, are extremely sensitive to agents that
induce ICLs, such as cisplatin, melphalan, or mitomycin C (MMC)
[7], [12], [13]. This sensitivity is reversed by complementation of
FA-J cells with wild-type FANCJ (FANCJWT), but not with
catalytically inactive FANCJ mutants [6], [8], [14]. Interestingly,
the mechanism by which FANCJ mediates ICL processing is
regulated by BRCA1 binding. HR is favored when BRCA1 binds
FANCJ. When BRCA1 binding is prevented, lesion bypass is
favored by a mechanism requiring the translesion synthesis
polymerase polg [9]. Thus, complementation of FA-J cells with
a BRCA1-interaction defective mutant FANCJS990A reverses ICL
sensitivity but does not fully restore FANCJ function.
Here, we present evidence that FANCJ contributes to lesion
processing by promoting a robust DDR. Essential for this function
is FANCJ acetylation on a specific lysine residue. As such,
preventing FANCJ acetylation suppresses DNA end resection that
normally serves to engage recombination-based processing. Thus,
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both BRCT-interacting proteins, CtIP and FANCJ undergo DNA
damage induced changes in acetylation that further regulates their
function in the DDR to promote genomic stability.
Results
FANCJ is acetylated by CBP and deacetylated by HDAC3
or SIRT1
As observed for CtIP, FANCJ binds directly to the BRCT
domains of BRCA1 [6], [9], [15]. Given that CtIP function is
inactivated by acetylation [16], we addressed whether FANCJ was
similarly modified. For this analysis, myc-tagged FANCJ was co-
transfected with various Flag- or HA-tagged histone acetyltrans-
ferases. In an immunoblot probed with a pan-acetyl lysine
antibody, we found that the precipitated FANCJ was acetylated
only when CBP was over-expressed (Figure 1A). Moreover,
FANCJ acetylation was induced by CBP in a dose dependent
manner (Figure 1B).
FANCJ acetylation was preserved most effectively by the
inclusion of two types of deacetylase inhibitors, trichostatin-A
(TSA) and nicotinamide (NAM) (Figure 1C). Thus, we considered
that more than one class of histone deacetylase (HDAC) could
deacetylate FANCJ. TSA inactivates class 1 and class II HDACs,
whereas NAM inactivates the nicotinamide adenoine dinucleotide
(NAD+)-dependent sirtuin (class III) family of HDACs (including
SIRT1 to SIRT7) [17]. FANCJ acetylation was reduced more
when either Flag-tagged-HDAC3 or SIRT1 were overexpressed in
293T cells than observed upon overexpression of HDAC1,
HDAC2, or SIRT6 (Figure 1D). Titration of the SIRT1
expression vector transfected into 293T cells revealed that
0.01 mg of the SIRT1 construct matched the expression level of
4 mg of the HDAC3 construct. At this similar level of expression,
HDAC3 more efficiently deactylated FANCJ than did SIRT1
(Figure 1E). Together, these data implicate that FANCJ can be
acetylated by CBP and deacetyated by HDAC3 as well a SIRT1
when over-expressed.
FANCJ is acetylated at lysine residue 1249
To identify the FANCJ acetylation site(s), myc-tagged C-
terminal FANCJ truncation mutants were co-transfected with
CBP into 293T cells. By Immunoblot analysis using the pan-acetyl
antibody, we found that acetylation of FANCJ required amino
acids 1239 to 1249 (Figure 2A, 2C). Consistent with this region
being modified, a C-terminal domain of FANCJ similar to a C-
terminal p53 control was acetylated in vitro by a HAT-domain
protein (Figure 2B, 2C). To determine, which of three lysine (K)
residues in this C-terminal region were required for acetylation, we
generated three independent FANCJ mutant constructs that
converted lysines 1240, 1242, or 1249 to arginine (R). Further
transfection experiments revealed that the K1249 was the
dominant site for FANCJ acetylation, a lysine that is not conserved
in chicken or C. elegans FANCJ species (Figure 2D, 2E).
Next, we sought to provide more conclusive evidence that CBP-
induced acetylation on FANCJ was at the K1249 site. We purified
FANCJ from 293T cells transfected with a C-terminal myc-tagged
FANCJWT or the FANCJK1249R mutant species by immunopre-
cipitation using a myc antibody. Isolated proteins were then
digested with trypsin and subjected to tandem mass spectrometry
analysis (LC-MS/MS). FANCJ-derived peptides covering the
entire sequence were analyzed, and acetylation sites were
identified using MASCOT search algorithm. Most of the
acetylated lysine residues were detected in overlapping peptides
derived from at least two independent protein preparations. In the
FANCJWT, one of these sites was K1249 (Figure 2F). Interestingly,
even though by antibody detection, the FANCJK1249R mutant
scores unmodified as in Figure 2D; FANCJWT and FANCJK1249R
mutant had three additional acetylation marks detected by mass
spectrometry (Figure S1). Furthermore, the K1249R mutant had
five additional acetylated lysines not found in wild-type FANCJ,
suggesting that these sites are not available when K1249 is
acetylated (Figure S1). Thus, immunoblot and mass spectrometry
analysis confirm that the very last amino acid of FANCJ, lysine
1249 is acetylated.
FANCJ acetylation is enhanced by certain forms of DNA
damage
Given that DNA damage reduces CtIP acetylation [16], we
addressed whether DNA damage could alter FANCJ acetylation.
Endogenous FANCJ acetylation was enhanced in MCF7 cells
treated with zeocin, camptothecin (CPT), or hydroxyurea (HU) as
compared to ultraviolet radiation (UV), MMC, or methyl
methanesulfonate (MMS) at the dose and time-post treatment
analyzed (Figure 3A). Notably, zeocin had a more robust induction
of FANCJ acetylation despite the dose of zeocin, CPT, or UV
having similar affect on cell survival (Figure S2; data not shown).
As found previously, DNA damage did not measurably alter
FANCJ co-precipitation with BRCA1 with the exception of UV
damage, which could reflect the UV-induced BRCA1 degradation
[11], [18] (Figure 3A). DNA damage also induced FANCJ
acetylation in HeLa cells, in response to not only CPT, but also
MMC (Figure 3A). In response to DNA damage, we also noted
that FANCJ protein levels were sometimes enhanced (Figure 3A).
To clarify whether acetylation or our ability to detect acetylation
was induced by DNA damage, we sought to induce DNA damage
in cells in which our ability to detect FANCJ acetylation was not
limiting. Indeed, the amount of acetylation on similar levels of
exogenous FANCJWT achieved with low dose CBP expression was
considerably enhanced following treatment with zeocin or CPT
(Figure 3B, 3C). Interactions with BRCA1 and MLH1 were not
required for the CBP-induced acetylation of FANCJ, because
BRCA1- and MLH1-interaction-defective mutants, FANCJS990A
Author Summary
The BRCA1–Fanconi anemia (FA) pathway is required for
both tumor suppression and cell survival, particularly
following treatment with DNA damaging agents that
induce DNA interstrand crosslinks (ICLs). ICL processing by
the BRCA–FA pathway includes promotion of homologous
recombination (HR) and DNA damage tolerance through
translesion synthesis. However, little is known about how
the BRCA–FA pathway or these ICL processing mecha-
nisms are regulated. Here, we identify acetylation as a DNA
damage–dependent regulator of the BRCA–FA protein,
FANCJ. FANCJ acetylation at lysine 1249 is enhanced by
expression of the histone acetyltransferase CBP and
reduced by expression of histone deacetylases HDAC3 or
SIRT1. Furthermore, acetylation on endogenous FANCJ is
induced upon treatment of cells with agents that generate
DNA lesions. Consistent with this post-translation event
regulating FANCJ function during cellular DNA repair,
preventing FANCJ acetylation skews ICL processing. Cells
have reduced reliance on HR factor Rad54 and greater
reliance on translesion synthesis polymerase polg. Our
data indicate that FANCJ acetylation contributes to DNA
end processing that is required for HR. Furthermore,
resection-dependent checkpoint maintenance relies on
the dynamic regulation of FANCJ acetylation. The implica-
tion of these findings is that FANCJ acetylation contributes
to DNA repair choice within the BRCA–FA pathway.
FANCJ Acetylation Promotes the DNA Damage Response
PLoS Genetics | www.plosgenetics.org 2 July 2012 | Volume 8 | Issue 7 | e1002786
and FANCJK141/142A were readily modified (data not shown). In
contrast, following treatment with CPT, acetylation was not
detected on the FANCJK1249R mutant (Figure 3C), indicating that
DNA damage-induced FANCJ acetylation requires the C-terminal
K1249 residue. It remains to be determined, however if FANCJ
acetylation is induced by a distinct type of DNA damage.
FANCJ acetylation mutants are functional
The enhanced FANCJ acetylation following DNA damage led
us to hypothesize that this modification facilitated FANCJ function
in DNA repair. To address this possibility, we made use of this
lysine to arginine FANCJK1249R mutant that prevents acetylation
and also generated a lysine to glutamine FANCJK1249Q mutant to
Figure 1. CBP promotes, and HDAC3 and SIRT1 reduce, FANCJ acetylation. A. CBP expression promotes FANCJ acetylation. Myc-tagged
FANCJ was co-transfected with HA- or FLAG-tagged acetyltransferase (CBP, p300, PCAF, Tip60, or MOF) into 293T cells. As detected by immunoblot of
whole cell extracts (WCE), acetyltransferases were expressed (upper panel), however only CBP promoted FANCJ acetylation as shown by FANCJ
immunoprecipitation (lower panel). B. FANCJ acetylation is induced by CBP in a dose dependent manner. Myc-tagged FANCJ was co-transfected with
increasing amounts of CBP and lysates were used for immunoblot with the indicated antibodies. C. FANCJ deacetylation was prevented by both TSA
and NAM. 293T cells co-expressing Myc-tagged FANCJ and CBP were exposed to TSA, NAM, TSA+NAM, or neither and lysates were used for
immunoblot with the indicated antibodies. D. FANCJ was deacetylated by both HDAC3 and SIRT1. Myc-tagged FANCJ was co-transfected with CBP
and Flag-tagged deacetylase (HDAC1, HDAC2, HDAC3, SIRT1, or SIRT6) into 293T cells and lysates were immunobloted with the indicated antibodies.
E. When SIRT1 (0.01 mg) and HDAC3 (4 mg) were similarly expressed (upper panel), HDAC3 promoted more FANCJ deacetylation (lower panel). Cell
lysates were collected and analyzed for expression and/or acetyation following immunoprecipitation with the indicated antibodies.
doi:10.1371/journal.pgen.1002786.g001
FANCJ Acetylation Promotes the DNA Damage Response
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structurally mimic acetylation. Consistent with these mutants
being functional, the purified recombinant proteins displayed
similar catalytic activities as FANCJWT (Figure S3). In addition,
they were expressed at similar levels as FANCJWT in FANCJ-null
FA-J cells (Figure 4A). Similar to FANCJWT, FANCJK1249R and
FANCJK1249Q precipitated with known FANCJ interacting
partners, BRCA1 and MLH1 [6], [8] (Figure 4B). In addition,
the mutants co-localized with BRCA1 in response to DNA
damage and the FA-J cells expressing FANCJWT or mutants had
similar asynchronous cell cycle profiles (Figure 4C, 4D). The
acetylation mutants also restored MMC resistance and the ability
of FA-J cells to exit from an abnormal G2/M accumulation, albeit
in a manner slightly more robust than FANCJWT (Figure 4E, 4F).
Together, these findings suggested that the mutants were enzyme
active and functional in vivo; however the mechanism by which the
FANCJ mutants restore ICL resistance could be distinct from
FANCJWT.
FANCJ acetylation contributes to the mechanism of
lesion processing
Previously, complementation of FA-J cells with a BRCA1-
binding defective mutant, FANCJS990A gave the semblance of
FANCJWT function. In particular, MMC resistance was restored
[8]. However, in contrast to FANCJWT, FANCJS990A provides
resistance to MMC by a mechanism dependent on the DNA
damage tolerance pathway. Within this tolerance pathway,
translesion synthesis polymerases can bypass DNA lesions such
as unhooked ICLs and intra-strand crosslinks generated by UV,
but not DSBs generated by zeocin. Evidence that FANCJS990A
skewed lesion processing towards DNA damage tolerance was
Figure 2. FANCJ is acetylated at lysine 1249. A. The C-terminus of FANCJ is required for acetylation. Myc-tagged FANCJ mutant constructs were
co-expressed with CBP into 293T cells. Cell lysates were collected and analyzed for expression and/or acetylation following immunoprecipitation with
the indicated antibodies. B. The FANCJ C-terminus is acetylated in vitro. The recombinant histone acetyltransferase (HAT) domain of p300 was
incubated with recombinant FANCJ C-terminal (CT) or p53-CT in the presence of 3H-acetyl CoA. Reaction products were separated by SDS-PAGE and
analyzed by autoradiography. Expression of recombinant proteins was determined by Coomassie staining. C. Schematic presentation of wild-type
and truncation mutations of FANCJ. D. Lysine 1249 is required for FANCJ acetylation. The Myc-tagged FANCJ mutant constructs noted were co-
expressed with CBP into 293T cells and cell lysates were collected and analyzed for expression and/or acetylation following immunoprecipitation with
the indicated antibodies. E. Sequence alignment of last 6 residues found in distinct FANCJ species. F. Confirmation of the K1249 acetylation is shown
by tandem mass spectrum of FANCJ peptide (amino acid 1243–1249 with Myc tag). *Ions validating localization of acetylation site.
doi:10.1371/journal.pgen.1002786.g002
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Figure 3. FANCJ acetylation is induced after DNA damage. A. Endogenous FANCJ is acetylated in response DNA damage. MCF7 and HeLa
cells were left untreated (UT) or treated with zeocin (6.25 mg/ml for 1 h), MMC (250 nM for 1 h), UV (30 J/m2), MMS (300 mg/ml for 4 h), HU (1 mM for
24 h), or CPT (1 mM for 1 h). Cell lysates were collected at distinct times post damage (zeocin 24 h, MMC 24 h or as indicated, UV 6 h, CPT 24 h, MMS
4 h, and HU 24 h) and analyzed for expression and/or acetylation following immunoprecipitation with the indicated antibodies. B. Exogenous FANCJ
is acetylated on lysine 1249 in response to DNA damage. Myc-tagged FANCJ wild-type or mutant species and CBP were co-transfected into 293T cells
and left untreated (UT) or treated with zeocin (12.5 mg/ml for 1 h or C. CPT (1 mM for 1 h). Cells were processed at different time points post DNA
damage and analyzed for expression and/or acetylation following immunoprecipitation with the indicated antibodies.
doi:10.1371/journal.pgen.1002786.g003
FANCJ Acetylation Promotes the DNA Damage Response
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based on several findings. First, the sensitivity to MMC in these
cells was restored upon depletion of the essential tolerance factor,
Rad18 or the translesion polymerase polg, but not upon depletion
of the HR protein, Rad54. Second, in comparison to FANCJWT,
cells expressing FANCJS990A were hyper-resistant to UV, a
phenotype that was reversed upon polg-depletion. Third, in
comparison to FANCJWT, FANCJS990A-expressing cells were
sensitive to zeocin, indicating reduced DSBR [9]. Thus, we
sought to determine whether similar to the BRCA1-binding
mutant, the acetylation mutants also functioned differently from
FANCJWT. To test this idea, the FA-J cell lines were left untreated
or treated with increasing doses of MMC, zeocin, or UV. In
comparison to the other FA-J cell lines, the FA-J cell line
expressing the acetylation mutant FANCJK1249R was hyper-
resistant to UV, but unable to restore normal levels of zeocin
resistance. In contrast, the FA-J cell line expressing the acetylation
mimic FANCJK1249Q displayed greater resistance to zeocin
(Figure 5A; Figure S2). Thus, in response to UV and zeocin, cells
expressing the acetylation mutants are distinct from each other as
well as from cells expressing FANCJWT.
To further validate these results, we targeted recombination or
DNA damage tolerance pathways by using siRNA reagents to
Rad54 or polg. Significantly, depletion of Rad54 suppressed the
zeocin resistance of the FA-J cell line expressing FANCJK1249Q
(Figure 5A, 5C). Likewise, depletion of polg suppressed the UV
hyper-resistance of the FA-J cell line expressing FANCJK1249R
(Figure 5A, 5C). Furthermore, depletion of polg, but not Rad54
reversed the MMC resistance of the FA-J cell line expressing
FANCJK1249R (Figure 5B). In contrast, depletion of Rad54, but not
polg reduced the MMC resistance of the FA-J cell line expressing
FANCJK1249Q (Figure 5B). Together, these results indicate that the
acetylation of FANCJ at lysine 1249 contributes to the mechanism
of lesion processing; preventing acetylation favors DNA damage
tolerance and constitutive acetylation favors recombination.
Figure 4. FANCJ acetylation mutants are functional. A. The acetylation mutants are expressed in FA-J cells. FA-J cells were complemented with
vector, FANCJWT, FANCJK1249R, or FANCJK1249Q. The FA-J cell lines were collected and analyzed or B. lysates were immunoprecipitated with FANCJ
antibodies and immunoblot was performed with the indicated antibodies. C. The acetylation mutants localize in nuclear foci of FA-J cells. The FA-J
cell lines were seeded onto 6-well plates and incubated overnight. The cells were treated with 1 mM HU and 24 h later immunoflourescence was
performed with the indicated antibodies. D. The FA-J cell lines have similar cell cycle profiles. The FA-J cells lines were collected and analyzed by FACS
to determine the percentage of cells with 2N and 4N DNA content. E. Expression of acetylation mutants restores MMC resistance. The FA-J cell lines
were seed onto 6 well plates and incubated overnight. The cells were either left untreated or treated with increasing doses of MMC. Cells were
counted 8 days later and percent survival was calculated. Data represent mean percent 6 s.d. of survival from three independent experiments. F.
Expression of acetylation mutants restores G2/M checkpoint exit. The FA-J cell lines were untreated or treated with 0.25 mg/ml melphalan, collected
at the indicated times, and analyzed by FACS to determine the percentage of cells in G2/M. Data represent mean percent6 s.d. of survival from three
independent experiments.
doi:10.1371/journal.pgen.1002786.g004
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FANCJ acetylation is required for a robust DDR
How could FANCJ acetylation affect lesion processing? Because
both CtIP and FANCJ are acetylated and directly bind to the
BRCA1-BRCT domain, we speculated that FANCJ might
similarly have a role in DNA end resection. In particular, the
affect of CtIP acetylation on DNA end resection was analyzed in
response to CPT [16]. We found RPA foci formation at 1 h post-
CPT was more robust (64% and 65%) in the FANCJWT and
FANCJK1249Q FA-J cell lines as compared to vector and
FANCJK1249R FA-J cell lines that had 47% and 29%, respectively
Figure 5. FANCJK1249R or FANCJK1249Q promotes polg- or Rad54-dependent repair, respectively. A. FA-J cells expressing acetylation
mutants have a distinct response and reliance on repair or tolerance factors for DNA damage survival. The FA-J cell lines were transfected with siRNA
against Luc, Polg, or Rad54. The cells were treated with indicated doses of zeocin, UV, or as in B., with MMC and the percent survival was calculated 8
days later. Data represent mean percent 6 s.d. of survival from three independent experiments. C. Cells were collected and analyzed for expression
with the indicated antibodies.
doi:10.1371/journal.pgen.1002786.g005
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(Figure 6A). Thus, as measured by RPA foci formation, FANCJWT
and the acetylation mimic FANCJK1249Q were more active in
DNA end resection.
RPA loading onto ssDNA also leads to its subsequent
phosphorylation on Ser4 and Ser8 [3]. We found that the FA-J
cell lines had a similar phosphorylation of Chk2 and c-H2AX
following exposure to two different dose of CPT, indicating that
FANCJ or its ability to be acetylated is not required for DSB
formation in response to CPT (Figure 6B). Likewise, at 1 h post-
CPT treatment, Chk1 phosphorylation was detected (Figure 6B).
In contrast, RPA phosphorylation was most robust in the CPT-
treated FANCJWT and FANCJK1249Q FA-J cell lines (Figure 6B).
In support of these findings, reduced RPA phosphorylation was
also detected in CPT-treated FANCJ-deficient U2OS cells
generated by siRNA reagents (Figure S4). Furthermore, at 4–
24 h post CPT treatment, we noted diminished RPA phosphor-
ylation in FANCJK1249R as compared with FANCJWT and
FANCJK1249Q FA-J cell lines (Figure 6C). At this time, RPA
phosphorylation in the FANCJK1249R FA-J cells was also reduced
compared to vector FA-J cells that had gained considerable RPA
phosphorylation as compared to 1 h post-CPT (Figure 6B, 6C). In
the response to zeocin, which induces DSBs independent of
replication, RPA phosphorylation was similar in FA-J cell lines
with or without FANCJWT (Figure S5). Together, these results
suggest a role for FANCJ and its acetylation in DNA end resection
at stalled replication forks as induced by CPT.
To address whether the contribution of FANCJ acetylation to
DNA end resection was sufficient to enhance HR, we next
analyzed Rad51 foci formation. In response to CPT, we found
that Rad51 foci were the most robust in FA-J cells complemented
Figure 6. FANCJ and its acetylation at 1249 promote an RPA response. A. Deficiency in FANCJ or its acetylation impairs the CPT-induced RPA
focus formation. The FA-J cell lines were seeded onto 6-well plates, incubated overnight, left untreated or treated with CPT 1 h and
immunoflourescence was performed with the indicated antibodies. The percent of cells with RPA foci was quantified and graphed. Data represent
mean 6 s.d. from three independent experiments. B. FANCJ and its acetylation promote RPA phosphorylation at 1 h post-CPT. The complemented
FA-J cell lines were either left untreated or treated for 1 h with the indicated dose of CPT and analyzed 1 h post-treatment. Cell lysates were collected,
lysed, and analyzed with the indicated antibodies. C. FANCJ acetylation promotes RPA phosphorylation at times greater than 1 h post-CPT. Same as
above but collected at the time points indicated.
doi:10.1371/journal.pgen.1002786.g006
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with FANCJWT or the FANCJK1249Q mutant. Instead, Rad51 foci
in the FA-J cells with vector or FANCJK1249R were more anemic
(Figure 7A). Furthermore, a greater number of FANCJK1249Q
expressing FA-J cells were positive for Rad51 foci as quantitated
between 2–16 h after CPT treatment (Figure 7A). In contrast, the
c-H2AX foci did not have a significant difference between the FA-
J cells lines. Thus, a greater proportion of c-H2AX co-staining
Rad51 foci were detected in FANCJK1249Q or FANCJWT, as
compared to vector or FANCJK1249R expressing FA-J cells
(Figure 7A merge). Together, these findings demonstrate that in
response to CPT, FANCJ and its acetylation at 1249 promote
DNA end processing events that enhance RPA phosphorylation,
and both RPA and Rad51 focal accumulation.
Given these findings and the recent identification that FANCJ
promotes checkpoint maintenance [10], we considered that
FANCJ acetylation could be essential for maintaining the
checkpoint. Defects in checkpoint maintenance were evaluated
by determining if CPT treated FA-J cells traversed prematurely to
mitosis. FA-J cells lacking FANCJWT entered mitosis by 24 h post-
CPT as indicated by a positive histone H3 phosphorylation
(Figure 7B). These results are consistent with FANCJ acetylation
supporting checkpoint maintenance. However, FA-J cells express-
ing FANCJK1249R or FANCJK1249Q also failed to maintain the
checkpoint, showing H3 phosphorylation by 24 h (Figure 7B).
Substantiating this finding, at time points greater than 4 h post-
CPT treatment, both mutants had reduced Chk1 phosphorylation
as compared to FA-J cells expressing FANCJWT (Figure 7B).
Collectively, these findings suggest that FANCJ acetylation
enhances the initial DDR to facilitate recombination-based repair
and limit translesion synthesis. Checkpoint maintenance however,
requires FANCJ and its dynamic regulation by acetylation
(Figure 7C).
Discussion
Here we identify acetylation as a DNA damage-dependent
regulator of the BRCA-FA protein, FANCJ. We show that
acetylation at lysine 1249 is a critical regulator of FANCJ function
during cellular DNA repair. We analyzed the expression of two
FANCJ mutants that mimicked either the constitutive deacetylated
FANCJK1249R or acetylated FANCJK1249Q protein isoforms. While
the mutants functioned similar to FANCJWT in several assays and
restored MMC resistance and exit from an abnormal G2/M
checkpoint response to FA-J cells, the mutants were distinct from
FANCJWT with respect to lesion processing. Notably, FA-J cells
expressing the acetylation mutants differentially relied on repair
and tolerance factors for resistance to DNA damaging agents. Our
findings further demonstrate that FANCJ has the ability to
potentiate HR and DNA damage induced acetylation is important
for this function.
Another BRCA1-BRCT interacting protein, CtIP is acetylated
and functions in DNA end resection. Thus, we considered that
recombination-based lesion processing by the FANCJ acetylation
mimic, FANCJK1249Q resulted from a function for FANCJ
acetylation in DNA end resection. To test this idea, the FA-J
cells were treated with CPT, which generates breaks in S-phase.
Indeed, FA-J cells expressing the acetylation mutants were distinct
in the initial response to CPT. Specifically, FA-J cells expressing
the FANCJK1249Q, but not FANCJK1249R, promoted DNA end
resection post-CPT exposure as measured by presentation of RPA
foci or its phosphorylation at serine residues 4 and 8. Furthermore,
FA-J cells expressing the FANCJK1249Q, as compared to
FANCJK1249R had 2.5-fold more cells with CPT-induced Rad51
foci. This more robust DDR could reflect a role for FANCJ
acetylation in loading RPA, as shown for FANCJ in response to
HU [19]. Our data do not implicate a global role for FANCJ in
DNA end resection given that FANCJ-deficiency did not affect the
amount of RPA phosphorylation following zeocin, an agent that
induces DSBs independent of replication. However, FANCJ is
acetylated when cells are exposed to CPT or zeocin. Thus, DSB-
induced FANCJ acetylation that is not associated with stalled or
broken replication forks may contribute to some other aspect of
the DDR, such as checkpoint maintenance.
In fact, we find that FANCJ as well as its acetylation are
essential for checkpoint maintenance. Specifically, in the absence
of FANCJ or its DNA damage induced acetylation, Chk1
phosphorylation was induced, but not maintained and corre-
spondingly cells underwent a more rapid transit into mitosis post-
CPT. Interestingly, we found that similar to FA-J cells expressing
the acetylation mutant FANCJK1249R, FA-J cells expressing the
acetylation mimic FANCJK1249Q failed to maintain the checkpoint
despite an initial DDR to CPT. Thus, some other aspect of
checkpoint signaling is perturbed in FA-J cells that express the
acetylation mimic. Perhaps this mutant fails to mediate a protein
interaction or act upon a DNA substrate important for checkpoint
maintenance. Instead FANCJ acetylation could serve as a switch,
in which acetylation and de-acetylation is essential to maintain the
checkpoint (Figure 7C). Consistently, a role for FANCJ in
checkpoint maintenance was reported in a recent study [10].
It follows that defects in initiating the DDR, engaging HR, and
maintaining the checkpoint impact cellular DNA damage resis-
tance. Reduced DNA repair and/or checkpoint maintenance
defects could explain why FA-J cells expressing the acetylation
mutant FANCJK1249R were sensitive to zeocin. Defects in repair
and in maintaining the checkpoint may not increase cellular
sensitivity if backup lesion processing mechanisms serve to process
or bypass the lesion. Compensatory pathways could explain the
lack of CPT-sensitivity in the FA-J cells with or without acetylation
mutants (Figure S2). In support of this idea, our data reveal that
FA-J cells expressing the acetylation mutant were resistant to DNA
damage by relying on tolerance factors. As such, depletion of polg
in FA-J cells expressing the non-acetylatable FANCJK1249R mutant
reversed the UV and MMC resistance. Instead, FA-J cells
expressing the acetylation mimic FANCJK1249Q maintained zeocin
and MMC resistance in a Rad54-dependent manner. These
findings suggest that the toxicity to ICLs lesions as found in cells
deficient for FANCJ is avoided because FANCJ enzyme active
acetylation mutants facilitate recombination in S phase or
translesion synthesis bypass of unhooked ICL lesions perhaps in
mitosis. In the absence of a maintained checkpoint, however
recombination similar to translesion synthesis bypass is likely to be
error-prone.
Previously, we found that BRCA1 binding to FANCJ altered
FANCJ function in HR and translesion synthesis pathways.
Indeed, we find that similar to FA-J cells expressing the acetylation
FANCJK1249R mutant, FA-J cells expressing the BRCA-interaction
defective mutant, FANCJS990A were hyper-resistant to UV
induced damage, sensitive to zeocin induced damage, and relied
on polg for MMC resistance [7]. Data also indicate that similar to
FANCJK1249R, the FANCJS990A mutant fails to maintain the
checkpoint. In response to melphalan treatment, FA-J cells
expressing the FANCJS990A mutant, as compared to FANCJWT,
underwent a reduced and more rapid G2/M checkpoint exit [7].
These similar outcomes do not reflect common defects in BRCA1
binding or acetylation. Indeed, the FANCJS990A mutant was
acetylated upon co-transfection of CBP to levels similar to those
observed for FANCJWT (data not shown). Moreover, co-precip-
itation experiments demonstrated that the FANCJK1249R mutant
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bound BRCA1 as well as FANCJWT. Thus, BRCA1 binding and
acetylation of FANCJ may be distinct events. Nevertheless, defects
in BRCA1 binding at serine 990 or acetylation at lysine 1249
could have similar outcomes for FANCJ function because both
mutants fail to maintain a robust checkpoint and Rad51-based
repair is reduced [9].
A stalled replication fork with exposed single stranded and
double stranded regions could provide an ideal DNA substrate for
FANCJ. Indeed, FANCJ requires several nucleotides for binding
and metabolizing DNA [20]. FANCJ function in replication fork
processing could also be similar to other 59-39 DNA helicase/
translocases such as Ecoli RecD and yeast Rad3. Rad3 facilitates
exonucleolytic degradation of DNA ends, which restricts recom-
bination between short homologous sequences [21]. Interestingly,
RecD regulates resection and recombination by changes in
helicase speed, which can also facilitate a polymerase swap, in
which bypass polymerases diminish fork break down [22].
Conceivably, enhanced FANCJ enzyme activity or altered
substrate preference due to acetylation could generate more
single-stranded DNA to elicit checkpoint responses such as RPA
loading as proposed [19]. Alternatively, checkpoint maintenance
could require reduced FANCJ enzyme activity so that FANCJ
does not displace proteins from lesions, such as RAD51 or
interacting partners BRCA1, RPA and BLM helicase [6], [23–25].
In this context, it is worth noting that changes in motor speed have
been associated with FANCJ clinical mutants. The breast cancer
associated mutant, M299I is enzyme activating and both unwinds
and translocates DNA more efficiently than FANCJWT, whereas
the P47A mutant is enzyme inactivating [26], [27]. Whether
changes in FANCJ function derive from acetylation and/or
partners that bind via this modification remains to be determined.
Furthermore, based on our current data, it is unclear if distinct
DNA lesions selectively induce FANCJ acetylation.
In summary, our findings indicate that FANCJ has the ability to
potentiate HR through dual roles in DNA end processing and
checkpoint maintenance. These two functions require FANCJ
lysine 1249, a site not conserved in FANCJ orthologues such as
chicken FANCJ and C. elegans Dog-1. Interestingly, unlike in
human cells, FANCJ does not function in HR in chicken and C-
elegans systems [28], [29]. It is not surprising that regulators of
FANCJ acetylation state, HDACIII, SIRT1, and CBP have roles
in DNA repair and genomic stability [30–32]. It remains to be
determined, however, whether associated repair defects are related
to failure to regulate FANCJ acetylation. Complicating this
analysis, HDACIII, SIRT1, and CBP have many other histone
and non-histone protein substrates that also have role in DNA
repair and genomic stability. For example, SIRT1 deacetylation
plays an important role in regulating the function of DNA double
strand break repair proteins, such as Ku70 [33], WRN [34], and
NBS1 [35]. Moreover, p300/CBP functions to regulate the
activities of multiple proteins at the replication fork including
PCNA [36]. CBP also regulates the activity of other helicases,
including WRN [37]. Whether HDAC or HAT associated defects
derive from a failure to regulate FANCJ acetylation will be an
important question for future studies.
Materials and Methods
Cell lines
MCF7, HeLa, and 293T cells were grown in DMEM
supplemented with 10% fetal bovine serum and penicillin/
streptomycin (100 U/mL each). FA-J (EUFA30-F) cells were
cultured with 15% fetal bovine serum and penicillin/streptomycin
(100 U/mL each). FA-J cells were infected with the POZ retroviral
vector [38] containing no insert, WT, K1249R, or K1249Q
FANCJ inserts. Stable FA-J POZ cell lines were selected as before
[8].
Immunoprecipitation and Western blot assays
Cells were harvested, lysed, and processed for Western blot
analysis as described previously using an NETN lysis buffer
(20 mM Tris, 150 mM NaCl, 1 mM EDTA, and 0.5% NP-40)
containing 10 mM NaF and 1 mM NaVO3 [7]. For acetylation
detection, unless otherwise noted cells were lysed with 150 mM
NETN buffer supplemented with 10 mM TSA and 5 mM
nicotinamide. For c-H2AX detection, cell pellets were collected
and dissolved and boiled in 26 lysis buffer (50 mM Tris pH 6.8,
2% SDS, 1% B-ME). Antibodies used for immunoprecipitation
(IP) and Western blot assays include FANCJ polyclonal Abs E67
[26], b-Actin (Sigma), pRPA S3/4 (Bethyl), RPA (Bethyl), pChk1
S317 (Bethyl), Chk1 (Bethyl), pChk2 (Cell signaling), Chk2 (Cell
Signaling), c-H2AX S139 (Millipore), H2AX (Bethyl), Flag
(Sigma), HA (12C4), pan-acetylated lysine (Cell signaling),
MLH1 (BD Bioscience), BRCA1 monoclonal (ms110), pH 3
(Millipore), H3 (Abcam), polg (Abcam), Rad54 (Abcam), Rad51
(Abcam), and Myc monoclonal (9E10).
Cell cycle progression assay
FA-J stable cell lines were either mock treated or treated with
0.25 mg/ml of melphalan (Sigma) and incubated for various times.
Cells were fixed with 90% methanol in PBS overnight and then
incubated 10 min with PBS containing 30 mg/ml DNase-free
RNase A and 50 mg/ml propidium iodide. 16104 cells were
analyzed using a FACs Calibur instrument (Becton-Dickinson, San
Jose, CA). Aggregates were gated out and the percentage of cells in
G2/M was calculated using Flow Jo software.
Plasmid construction
The pCDNA3-myc.his vector (Invitrogen) was digested by
Not1/Apa1 and different FANCJ fragments generated by PCR
and digested by Not1/Apa1 were inserted. Primers are available
upon request. Reverse primers used for K1249R-pCDNA3 and
K1249RQ-pCDNA3 are 59TTTTGGGCCCCCTAAAACCAG-
GAAACATGCC39 and 59TTTTGGGCCCCTGAAAACCAG-
GAAACATGCC39, respectively. The K1249R and K1249Q
pOZ vectors were generated with the QuickChange Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA) by using the FANCJ-
pCDNA3-myc.his or FANCJ-pOZ as a template and the following
primers: (K1249R-pOZ-Forward) 59GGCATGTTTCCTGGT-
TTTAGGGCGGCCGCTGGAGGAGCA39 and (K1249R-
Figure 7. FANCJ and its dynamic regulation by acetylation promote resection-associated events. A. Deficiency in FANCJ or its
acetylation impairs the CPT-induced Rad51 focus formation. The FA-J cell lines were seeded onto 6-well plates, incubated overnight, left untreated or
treated with CPT 6 h and immunoflourescence was performed with the indicated antibodies. The percent of cells with c-H2AX and Rad51 foci was
quantified and graphed. Data represent mean percent 6 s.d. from three independent experiments. B. Deficiency in FANCJ or its ability to be
regulated by acetylation impairs the CPT-induced checkpoint response. FA-J cell lines were either left untreated or treated for 1 h with the 0.1 mM or
1 mM of CPT and analyzed at the indicated time points. Cell lysates were collected, lysed, and analyzed with the indicated antibodies. C. Model
depicts function of FANCJ acetylation in the DDR. FANCJ acetylation at lysine 1249 promotes resection and HR whereas de-acetylation promotes
translesion synthesis (TLS). Maintenance of the checkpoint response; however requires the dynamic regulation of FANCJ acetylation.
doi:10.1371/journal.pgen.1002786.g007
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pOZ-Reverse) 59GTCTCCTCCAGCGGCCGCCCTAAAAC-
CAGGAAACATGCC39; (K1239Q-pOZ-Forward) 59GGCA-
TGTTTCCTGGTTTTCAGGCGGCCGCTGGAGGAGAC39
and (K1239Q-pOZ-Reverse) 59GTCTCCTCCAGCGGCCGC-
CTGAAAACCAGGAAACATGCC39; Recombinant FANCJ
protein production was made in insect cells using the PVL13.2
vector as before [26]. Full-length WT FANCJ was used as a
template to generate the acetylation mutants using the following
primers: (K1249R-PVL132 Forward) 59GGCATGTTTCCTG-
GTTTTAGGGACTACAAGGAGACG39 and (K1249-PV132
Reverse) 59CGTCGTCCTTGTAGTCCCTAAAACCAGGAA-
ACATGCC39. (K1249Q-PVL132 Forward) 59 GGCATGTTT-
CCTGGTTTTCAGGACTACAAGGACGACG39 and (K1249Q-
PVL132 Reverse) 59 CGTCGTCCTTGTAGTCCTGAAAAC-
CAGGAAACATGCC39. The pGEX-5X vector (GE Healthcare
Life Sciences) was digested by Sal1/Not1 and the FANCJ C-
terminal fragment was generated by PCR and digested by Sal1/
Not1 and inserted. Primers are available upon request. All DNA
constructs were confirmed by DNA sequencing.
Viability assays
Stable FA-J cell lines were untransfected or transfected with
siRNA previously described against Luc, Rad54, or polg [9]. Cells
were seeded onto 6 well plates and incubated overnight. Seeded
cells were either untreated or treated with increasing dose of
MMC (1 h, serum free), UV, CPT, (1 h, serum free), or zeocin
(1 h, serum free). To assay for percent survival, cells were counted
5–8 days post infection and percent survival was calculated as
before [9].
Helicase assays
Helicase assay reaction mixtures (20 ml) contained 40 mM Tris-
HCl (pH 7.4), 25 mM KCl, 5 mM MgCl2, 2 mM dithiothreitol,
2% glycerol, 100 ng of bovine serum albumin/ml, 2 mM ATP,
10 fmol of 19-bp duplex DNA substrate (0.5 nM), and the
concentrations of FANCJ (acetylated or non acetylated) indicated
in the figures. Helicase reactions were initiated by the addition of
FANCJ, and the reaction mixtures were incubated at 30uC for
15 min unless otherwise indicated. Reactions were quenched with
the addition of 20 ml of 26 Stop buffer (17.5 mm EDTA, 0.3%
SDS, 12.5% glycerol, 0.02% bromophenol blue, 0.02% xylene
cyanol). For standard duplex DNA substrates, a 10-fold excess of
unlabeled oligonucleotide with the same sequence as the labeled
strand was included in the quench to prevent reannealing. Reaction
products were resolved on nondenaturing 12% (19:1 acrylamide-
bisacrylamide) polyacrylamide gels, and quantitated as described
previously [27].
Immnuofluorescence microscopy
Stable FA-J cell lines were seeded onto 6 well plates and
incubated overnight. Cells were either untreated or treated with
1 mM HU (24 h) or 0.25 mM CPT (1 h). Cells were fixed with 3%
paraformaldehyde/2% sucrose for 10 min at RT, and permeabi-
lized with 0.5% Triton X-100 in 20 mM HEPES for 5 min on ice.
Incubation with antibodies and washes were described previously
[6]. For Rad51 staining, cells were fixed with 3% paraformalde-
hyde/2% sucrose for 10 min at RT, permeabilized with ice-cold
methanol for 30 min, and blocked with 4% BSA for 1 h. Staining
was as described previously [6].
In vitro acetylation assay
The acetyltransferase assays were performed in 30 ml of
reaction, which includes reaction buffer (50 mM HEPES
(ph 8.0), 10% glycerol, 1 mM DTT, 1 mM PMSF, 10 mM Na-
butyrate), 1 mL [3H]-acetyl-CoA, 1 ml recombinant HAT domain
of p300 (gift of Dr. Luo), and recombination FANCJ-CT or p53-
CT [39]. Reaction were carried out at 30uC for 1 h and separated
by SDS-PAGE, analyzed by autoradiography. Concentrations of
recombinant proteins were determined by comassie staining from
Invitrogen.
In gel digestion
Gel bands containing FANCJ1 were de-stained twice with
25 mM ammonium bicarbonate in 50% acetonitrile for 30 min in
37uC, reduced with 7.6 mg/ml dithiothreitol at 60uC for 10 min,
and alkylated with 18.6 mg/mL iodoacetamide at room temper-
ature for 1 hour. The bands were then washed twice with 25 mM
ammonium bicarbonate in 50% acetonitrile for 15 min at 37uC
prior to shrinking with 50 mL acetonitrile for 10 min at room
temperature. 100 ng trypsin (Promega) was added to each sample
and 25 mM ammonium bicarbonate was added until the gels were
fully swollen (,10–50 mL) and the digestion proceeded overnight
at 30uC. Following digestion, peptide extracts were transferred
into new tubes and the gels were further extracted with 50 mL of
50% acetonitrile containing 5% formic acid (v/v) and following
15 min were added to the initial extracts. The latter process was
repeated for a total of three extractions. Extracts were then dried
on a SpeedVac and reconstituted in 20 mL of 0.1% formic acid for
LC-MS/MS analysis.
LC/MS/MS
Tryptic peptides (2 mL) were directly loaded at 4 mL/min for
7 min onto a custom-made trap column (100 mm I.D. fused silica
with Kasil frit) containing 2 cm of 200 A˚, 5 mm Magic C18AQ
particles (Michrom Bioresources). Peptides were then eluted using
a custom-made analytical column (75 mm I.D. fused silica) with
gravity-pulled tip and packed with 25 cm 100 A˚, 5 mm Magic
C18AQ particles (Michrom). Peptides were eluted with a linear
gradient from 100% solvent A (0.1% formic acid:acetonitrile
(95:05)) to 35% solvent B (acetonitrile containing 0.1% formic
acid) in 35 min at 300 nL/min using a Proxeon Easy nanoLC
system directly coupled to a LTQ Orbitrap Velos mass
spectrometer (Thermo Scientific) [40]. Data were acquired using
a data-dependent acquisition routine of acquiring one mass
spectrum from m/z 350–2000 in the Orbitrap (resolution
60,000) followed by tandem mass spectrometry scans in the
LTQ linear ion trap of the 10 most abundant precursor ions found
in the mass spectrum. Charge state rejection of singly-charged ions
and dynamic exclusion was utilized to minimize data redundancy
and maximize peptide identification [41].
Data analysis
The raw data files were processed and searched against the
human index of the SwissProt database (version 09/21/11)
containing both the mutant and wild-type forms of FANCJ1 with
Mascot (version 2.3.02; Matrix Science) using parent mass
tolerances of 15 ppm and fragment mass tolerances of 0.5 Da.
Full tryptic specificity with 2 missed cleavages was used and
variable modifications of acetylation (protein N-term and lysine),
pyro-glutamination (N-term glutamine), and oxidation (methio-
nine), and fixed modification of carbamidomethylation (cysteine)
were considered. Mascot search results were also loaded into
Scaffold (Version 3.3.1; Proteome Software) for comparative
analyses using spectral counting of tandem mass spectra and full
annotation of the data [42].
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Supporting Information
Figure S1 FANCJ acetylation sites. Identified acetylation sites of
FANCJ protein by mass spectrometry (bold): acetylated peptides
unique to WT (red); unique to K1249R mutant (green); and
common to both (black).
(EPS)
Figure S2 FA-J cells expressing FANCJ acetylation mutants
have a distinct response to UV and zeocin induced damage. The
FA-J cell lines were either untreated or treated with increasing
doses of UV, zeocin, or CPT and allowed to grow for 8 days. Cells
were counted and percent survival was calculated. Data represent
mean percent 6 s.d. of survival from three independent
experiments.
(EPS)
Figure S3 FANCJWT, FANCJK1249R, and FANCJK1249Q have
similar catalytic activities. FANCJWT, FANCJK1249R, and
FANCJK1249Q recombinant proteins were incubated with forked
duplex substrate at 30uC for 15 min. Reaction products were
analyzed by nondenaturing gel electrophoresis. Data represent
mean percent 6 s.d. of growth from three independent
experiments.
(EPS)
Figure S4 FANCJ is required for promoting CPT induced RPA
phosphorylation. U2OS cells stably expressing shLuc or shFANCJ
were either untreated or treated with CPT. Cell lysates were
collected and analyzed with the indicated antibodies.
(EPS)
Figure S5 FANCJ is not required for promoting zeocin induced
RPA phosphorylation. The FA-J cell lines were either untreated or
treated with the denoted dose of zeocin. Cell lysates were collected
and analyzed with the indicated antibodies.
(JPG)
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